Background: The Global Initiative for Asthma (GINA) recommends the concurrent use of self-report and pharmacy refill data to assess treatment adherence. However, clinical evidence to support this combined approach is limited. Objective: To determine nonadherence to inhaler medication based on a validated questionnaire (Test of Adherence to Inhalers; TAI) and prescription refill data in a community sample of patients with chronic obstructive pulmonary disease (COPD) or asthma. Secondarily, we sought to determine the degree of concordance between these two measures. Methods: Cross-sectional, observational multicenter study in patients with asthma or COPD. Sociodemographic and clinical data were obtained from clinical records. Refill data were retrieved from electronic pharmacy databases. Participants completed the 12-item TAI during a single visit as part of routine care. Nonadherence was defined as TAI <50 or <80% pharmacy refill rate (PRR) in the previous 6 months. Results: A total of 816 patients (mean age, 60) were included. Nonadherence rates were 58.1% (TAI) and 28.6% (PRR) compared with 64.6% for the combined data (P
CITATION STYLE
Plaza, V., Giner, J., Curto, E., Alonso-Ortiz, M. B., Orue, M. I., Vega, J. M., & Cosío, B. G. (2021). Assessing adherence by combining the test of adherence to inhalers with pharmacy refill records. Journal of Investigational Allergology and Clinical Immunology, 31(1), 58–64. https://doi.org/10.18176/jiaci.0461
Mendeley helps you to discover research relevant for your work.